Head-To-Head Comparison: Allianz (AZSEY) & Its Competitors

Share on StockTwits

Allianz (OTCMKTS: AZSEY) is one of 19 publicly-traded companies in the “Insurance agents, brokers, & service” industry, but how does it compare to its rivals? We will compare Allianz to similar businesses based on the strength of its valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations and risk.

Volatility & Risk

Allianz has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500. Comparatively, Allianz’s rivals have a beta of 0.85, suggesting that their average stock price is 15% less volatile than the S&P 500.

Dividends

Allianz pays an annual dividend of $0.70 per share and has a dividend yield of 3.2%. Allianz pays out 34.3% of its earnings in the form of a dividend. As a group, “Insurance agents, brokers, & service” companies pay a dividend yield of 1.6% and pay out 31.8% of their earnings in the form of a dividend.

Profitability

This table compares Allianz and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Allianz 5.71% 11.81% 0.83%
Allianz Competitors 7.10% 18.06% 9.00%

Institutional & Insider Ownership

0.2% of Allianz shares are held by institutional investors. Comparatively, 59.6% of shares of all “Insurance agents, brokers, & service” companies are held by institutional investors. 20.3% of shares of all “Insurance agents, brokers, & service” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Allianz and its rivals top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Allianz $154.19 billion $8.81 billion 10.81
Allianz Competitors $13.74 billion $1.13 billion 34.14

Allianz has higher revenue and earnings than its rivals. Allianz is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a breakdown of current ratings and price targets for Allianz and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Allianz 0 0 5 0 3.00
Allianz Competitors 184 676 765 39 2.40

As a group, “Insurance agents, brokers, & service” companies have a potential upside of 7.96%. Given Allianz’s rivals higher probable upside, analysts clearly believe Allianz has less favorable growth aspects than its rivals.

Summary

Allianz rivals beat Allianz on 9 of the 15 factors compared.

About Allianz

Allianz SE, together with its subsidiaries, provides property-casualty insurance, life/health insurance, and asset management products and services worldwide. The company's Property-Casualty segment offers various insurance products, including motor liability and own damage, accident, general liability, fire and property, legal expense, credit, and travel insurance products to private and corporate customers. Its Life/Health segment provides a range of life and health insurance products on an individual and a group basis, such as annuities, endowment and term insurance, and unit-linked and investment-oriented products, as well as private health, supplemental health, and long-term care insurance products. The company's Asset Management segment offers institutional and retail asset management products and services to third-party investors comprising equity and fixed income funds, as well as alternative products; and investment management services. Its Corporate and Other segment provides various banking products for corporate and retail clients; and alternative investment management services in the private equity, real estate, renewable energy, and infrastructure sectors. Allianz SE was founded in 1890 and is headquartered in Munich, Germany.

Receive News & Ratings for Allianz Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allianz and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Acer Therapeutics  PT Set at $55.00 by HC Wainwright
Acer Therapeutics PT Set at $55.00 by HC Wainwright
Amalgamated Bank Purchases New Holdings in TransEnterix, Inc.
Amalgamated Bank Purchases New Holdings in TransEnterix, Inc.
Scorpio Tankers Inc.  Shares Bought by Amalgamated Bank
Scorpio Tankers Inc. Shares Bought by Amalgamated Bank
15,519 Shares in R1 RCM Inc  Purchased by Amalgamated Bank
15,519 Shares in R1 RCM Inc Purchased by Amalgamated Bank
Ancora Advisors LLC Has $3.92 Million Holdings in CVS Health Corp
Ancora Advisors LLC Has $3.92 Million Holdings in CVS Health Corp
D. E. Shaw & Co. Inc. Invests $87,000 in Trivago NV –  Stock
D. E. Shaw & Co. Inc. Invests $87,000 in Trivago NV – Stock


 
© 2006-2019 Zolmax.